Table 2 Haemodynamic status and BAD occurrence at Day 90, univariate analysis

Haemodynamic status before LT

Catecholamine administration to the donor, n (%)

32 (84)

90 (86)

0.79

Catecholamine > 0.5 γ/kg/min to the donor, n (%)

6 (14)

14 (12)

0.79

Cardiac arrest of the donor, n (%)

13 (31)

33 (29)

0.84

RBC transfusion of the donor, n (%)

14 (37)

30 (29)

0.41

ECMO as a bridge to LT (recipient), n (%)

6 (14)

3 (3)

0.01

Haemodynamic status during LT surgery

Catecholamine > 0.5 γ/kg/min during surgery, n (%)

13 (31)

37 (32)

1.00

ECMO support during surgery, n (%)

37 (88)

80 (70)

0.02

ECMO weaned in operating room, n (%)

21 (50)

56 (50)

1.00

Vascular filling > 30 mL/kg, n (%)

38 (91)

98 (88)

0.78

Vascular filling > 2500 mL, n (%)

38 (91)

100 (89)

1.00

RBC transfusion, n (%)

31 (74)

75 (66)

0.44

 > 5 RBC units transfusion, n (%)

9 (22)

23 (20)

0.83

FFP transfusion, n (%)

30 (71)

70 (61)

0.27

Platelet transfusion, n (%)

15 (40)

29 (27)

0.15

Cardiac arrest during surgery, n (%)

1 (2)

6 (5)

0.68

Haemodynamic status during hospitalization in ICU

Lactate on ICU admission > 2 mmol/l, n (%)

21 (50)

56 (49)

1.00

Lactate on ICU admission > 3 mmol/l, n (%)

9 (21)

29 (25)

0.68

Catecholamines administration during hospitalization in ICU, n (%)

38 (93)

107 (96)

0.39

Duration of catecholamine administration, days, median [IQR]

2 [1–3, 5]

1 [1–3]

0.16

Duration of ECMO support, days, median [IQR]

0 [0–3]

0 [0–1]

0.06

Atrial fibrillation, n (%)

18 (43)

28 (25)

0.05

AKI, n (%)

29 (69)

23 (20)

 < 0.0001

KDIGO stage, median [IQR]

1 {0–2]

1 [0–2]

0.16

RRT, n (%)

5 (12)

11 (10)

0.77

Septic shock, n (%)

18 (43)

19 (17)

0.001

Haemorrhagic shock, n (%)

4 (10)

13 (11)

1

Cardiogenic shock, n (%)

5 (12)

7 (6)

0.31

MOF syndrome, n (%)

17 (42)

26 (23)

0.03

Cardiac arrest during hospitalization in ICU, n (%)

7 (17)

10 (9)

0.16